Subscribe

Alkermes plc (ALKS)

USD51.14 -0.73 (-1.41%)
IE NASDAQ Healthcare Biotechnology
Address Connaught House D04 C5Y6
Dublin, IE
CEO Richard F. Pops
IPO 1991-07-16
CIK 1520262 ISIN IE00B56GVS15

Explore sections of this company profile

Also trades on NASDAQ · ALKSV (USD) NASDAQ Global Select · ALKS (USD)
Description

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Market Cap & Enterprise Value
Merger & Acquisition History
Target company Date Filing
SHARE OPTIONS 2011-06-22 View
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD51.14 -0.73 (-1.41%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.33
Float Shares
163.20M
Free Float %
97.9%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+7.95% +7.05% +13.45% +15.47% +23.48% +36.85% +24.16% +23.52% +72.17% +2.24% +596.18%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (28 ratings, all time) Buy
Price Targets & DCF
Current price
51.14
Low 43.00 -15.9%
Consensus 46.00 -10.1%
Median 45.00 -12.0%
High 50.00 -2.2%
DCF (Unlevered) 43.72 -14.5%
DCF (Levered) 64.92 +26.9%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 83% Bullish
Rating 2026-05 Change
Strong Buy 3 0
Buy 12 0
Hold 3 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month 1
50.00
-2.2%
Last Quarter 3
46.00
-10.1%
Last Year 12
45.83
-10.4%
All Time 25
38.52
-24.7%
Quality scores
Altman Z-Score
1.95
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
    -5.3% Q1'26: +28.2% (vs Q1'25)
  • EPS growth Biotechnology: +29.7%
    -34.1% Q1'26: -407.7% (vs Q1'25)
  • FCF margin FCF growth · Biotechnology: +16.2%
    +24.5% Q1'26: -43.2% (vs Q1'25)
  • EBIT margin Biotechnology: +0.0%
    +20.6% Q1'26: -10.4% (vs Q1'25)
  • ROIC Biotechnology: -16.1%
    +44.2% Q1'26: -5.8% (vs Q1'25)
  • Share dilution Biotechnology: -3.4%
    -0.3% Q1'26: -1.5% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    0.21× Q1'26: -18.30× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.26) × ERP
WACC = 99% × Ke + 1% × Kd (17.5%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 43.19 Current price: 51.14
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2010
actual
Dec 2011
actual
Dec 2012
actual
Dec 2014
actual
Dec 2015
actual
Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
13 Rev. Ana.
8 EPS Ana.
Dec 2027
13 Rev. Ana.
5 EPS Ana.
Dec 2028
13 Rev. Ana.
8 EPS Ana.
Dec 2029
12 Rev. Ana.
6 EPS Ana.
Dec 2030
6 Rev. Ana.
6 EPS Ana.
Revenue
186.64M
est: 198.53M (-6.0%)
389.98M
est: 402.73M (-3.2%)
575.55M
est: 397.02M (+45.0%)
618.79M
est: 483.98M (+27.9%)
628.34M
est: 627.21M (+0.2%)
745.69M
est: 739.35M (+0.9%)
903.37M
est: 870.59M (+3.8%)
1.09B
est: 1.05B (+4.2%)
1.17B
est: 1.16B (+0.6%)
1.04B
est: 1.03B (+1.2%)
1.17B
est: 1.16B (+1.4%)
1.11B
est: 1.10B (+1.4%)
1.66B
est: 1.51B (+10.3%)
1.56B
est: 1.51B (+3.3%)
1.48B
est: 1.47B (+0.4%)
1.81B
1.78B – 1.84B
+23.2% YoY
1.89B
1.86B – 1.92B
+4.2% YoY
2.08B
2.07B – 2.08B
+9.9% YoY
2.32B
2.25B – 2.45B
+11.8% YoY
2.62B
2.54B – 2.77B
+12.8% YoY
EBITDA
-34.54M
est: -40.09M (+13.8%)
-38.40M
est: 7.17M (-635.8%)
158.19M
est: 76.31M (+107.3%)
97.49M
est: 89.66M (+8.7%)
-125.16M
est: -154.23M (+18.8%)
-105.24M
est: -115.49M (+8.9%)
-32.74M
est: -122.82M (+73.3%)
-7.87M
est: 228.67M (-103.4%)
-103.04M
est: -167.53M (+38.5%)
-6.02M
est: 170.32M (-103.5%)
177.60M
est: 368.30M (-51.8%)
59.77M
est: -106.83M (+156.0%)
519.48M
est: 319.46M (+62.6%)
494.86M
est: 319.31M (+55.0%)
330.89M
est: 311.53M (+6.2%)
383.77M
377.34M – 390.21M
+23.2% YoY
399.92M
393.51M – 406.34M
+4.2% YoY
439.62M
439.16M – 440.07M
+9.9% YoY
491.36M
476.59M – 519.92M
+11.8% YoY
554.18M
537.52M – 586.39M
+12.8% YoY
EBIT
-43.19M
est: -55.21M (+21.8%)
-86.28M
est: -41.15M (-109.7%)
84.44M
est: -31.85M (+365.1%)
-599.0K
est: -71.79M (+99.2%)
-210.76M
est: -322.79M (+34.7%)
-199.50M
est: -244.53M (+18.4%)
-131.27M
est: -366.93M (+64.2%)
-111.53M
est: -144.43M (+22.8%)
-183.46M
est: -273.90M (+33.0%)
-87.88M
est: 112.97M (-177.8%)
98.95M
est: -79.00M (+225.2%)
-18.09M
est: -362.85M (+95.0%)
444.55M
est: 253.47M (+75.4%)
466.33M
est: 253.35M (+84.1%)
303.73M
est: 247.18M (+22.9%)
304.50M
299.40M – 309.60M
+23.2% YoY
317.31M
312.22M – 322.40M
+4.2% YoY
348.81M
348.44M – 349.17M
+9.9% YoY
389.86M
378.14M – 412.52M
+11.8% YoY
439.70M
426.48M – 465.26M
+12.8% YoY
Net Income
-45.54M
est: -51.12M (+10.9%)
-113.68M
est: -62.90M (-80.7%)
24.98M
est: -62.63M (+139.9%)
-30.06M
est: -16.47M (-82.5%)
-227.16M
est: -334.77M (+32.1%)
-208.44M
est: -243.03M (+14.2%)
-157.95M
est: -361.63M (+56.3%)
-139.31M
est: -258.20M (+46.0%)
-196.62M
est: -308.67M (+36.3%)
-110.86M
est: 60.34M (-283.7%)
-48.17M
est: -151.10M (+68.1%)
-158.27M
est: -447.50M (+64.6%)
355.76M
est: 385.71M (-7.8%)
367.07M
est: 439.01M (-16.4%)
241.66M
est: 276.73M (-12.7%)
-34.90M
-47.75M – -22.04M
-112.6% YoY
176.79M
-3.10M – 258.82M
+606.6% YoY
219.91M
-34.09M – 511.42M
+24.4% YoY
392.69M
377.34M – 422.36M
+78.6% YoY
587.04M
564.10M – 631.40M
+49.5% YoY
SGA
82.85M
est: 87.57M (-5.4%)
137.63M
est: 127.62M (+7.8%)
125.76M
est: 91.03M (+38.2%)
199.91M
est: 169.46M (+18.0%)
311.56M
est: 510.01M (-38.9%)
374.13M
est: 462.71M (-19.1%)
421.58M
est: 408.70M (+3.2%)
526.41M
est: 493.03M (+6.8%)
599.45M
est: 905.78M (-33.8%)
538.83M
est: 482.08M (+11.8%)
549.61M
est: 543.66M (+1.1%)
590.75M
est: 514.87M (+14.7%)
689.75M
est: 694.79M (-0.7%)
645.24M
est: 694.47M (-7.1%)
701.52M
est: 677.56M (+3.5%)
834.68M
820.69M – 848.67M
+23.2% YoY
869.80M
855.85M – 883.76M
+4.2% YoY
956.13M
955.14M – 957.12M
+9.9% YoY
1.07B
1.04B – 1.13B
+11.8% YoY
1.21B
1.17B – 1.28B
+12.8% YoY
EPS
-0.48
est: -0.67 (+28.4%)
-0.99
est: -0.61 (-63.6%)
0.19
est: 0.11 (+81.0%)
-0.21
est: 0.30 (-170.0%)
-1.52
est: -0.37 (-315.8%)
-1.38
est: -0.20 (-584.3%)
-1.03
est: 0.06 (-1,787.9%)
-0.90
est: 0.26 (-446.6%)
-1.25
est: 0.40 (-416.4%)
-0.70
est: 0.36 (-296.3%)
-0.30
est: 0.58 (-151.3%)
-0.97
est: 0.23 (-519.9%)
2.14
est: 2.30 (-7.1%)
2.22
est: 2.62 (-15.3%)
1.47
est: 1.74 (-15.6%)
-0.24
-0.28 – -0.13
-114.0% YoY
0.62
-0.02 – 1.53
+356.9% YoY
1.36
-0.20 – 3.03
+117.4% YoY
2.33
2.24 – 2.50
+71.4% YoY
3.48
3.34 – 3.74
+49.5% YoY
Recent Grade Changes (3M)
Date Firm Previous New Grade Action
2026-05-06 Needham Buy Buy Maintain
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 B 3/5 5/5 4/5 4/5 1/5 1/5 2/5
2026-05-08 B 3/5 5/5 3/5 4/5 1/5 2/5 2/5
2026-05-07 B 3/5 4/5 3/5 4/5 1/5 2/5 2/5
2026-05-06 B 3/5 5/5 3/5 4/5 1/5 2/5 2/5
2026-05-05 B 3/5 4/5 3/5 4/5 1/5 2/5 2/5
2026-05-04 A 4/5 5/5 4/5 5/5 3/5 3/5 3/5
2026-05-01 A 4/5 4/5 4/5 5/5 3/5 3/5 3/5
2026-04-30 A 4/5 4/5 4/5 5/5 3/5 3/5 3/5
2026-04-29 A 4/5 4/5 4/5 5/5 3/5 3/5 3/5
2026-04-28 A 4/5 4/5 4/5 5/5 3/5 3/5 3/5
2026-04-27 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-24 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-23 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-22 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-21 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-20 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-17 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-16 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5
2026-04-15 A- 4/5 4/5 4/5 5/5 2/5 3/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
235.33M
OE per share TTM
1.38
Owner's Yield
3.70%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
27.9%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
83
Total invested
193.63M
Insider transactions (90d)
2
Beneficial owners (>5%)
11
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 The Vanguard Group - 23-1945930 16.89M 10.45% 303.8K 445.9K IA Pennsylvania 2022-02-09
2 Wellington Group Holdings LLP 15.24M 9.13% 14.62M HC Delaware 2024-02-08
3 Wellington Investment Advisors Holdings LLP 15.24M 9.13% 14.62M HC Delaware 2024-02-08
4 Wellington Management Group LLP 15.24M 9.13% 14.62M HC Delaware 2024-02-08
5 Wellington Management Company LLP 14.95M 8.96% 14.51M IA Delaware 2024-02-08
6 PRIMECAP Management Company 95-3868081 14.10M 8.95% 13.68M 14.10M IA 177 E. Colorado Blvd., 11th Floor, Pasadena, CA 91105 2020-02-12
7 Alexander J. Denner, Ph.D. 14.04M 8.68% 14.04M 10.00 IN United States 2022-01-10
8 Sarissa Capital Management LP 14.04M 8.68% 14.04M 10.00 PN Delaware 2022-01-10
9 52-0556948 13.00M 7.90% 12.93M 13.00M IA Maryland 2024-11-14
10 STATE STREET CORPORATION 9.35M 5.60% 8.74M 9.35M HC BOSTON, MASSACHUSETTS 2024-01-24
11 VANGUARD SPECIALIZED FUNDS - VANGUARD HEALTH CARE FUND - 23-2439149 0.00% IV Delaware 2020-02-12

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
83
-291 vs prev Q
New positions
12
Closed positions
292
Increased
35
Reduced
35
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 MACQUARIE MANAGEMENT HOLDINGS, INC. 361.4K +361.4K (+100.0%) 10.11B +10.1B (+100.0%) 0.22% +0.219 pp 0.02% +0.015 pp USD27.98 +0.0% 1 qtrs NEW
2 BLACKROCK, INC. 28.27M +300.3K (+1.1%) 791.06M -48.1M (-5.7%) 17.13% +0.169 pp 0.01% -0.001 pp USD28.01 -0.1% 6 qtrs
3 VANGUARD GROUP INC 18.01M -172.1K (-0.9%) 503.85M -41.5M (-7.6%) 10.91% -0.113 pp 0.01% -0.001 pp USD29.99 -6.7% 58 qtrs
4 BAKER BROS. ADVISORS LP 10.01M +1.9M (+23.7%) 280.14M +37.4M (+15.4%) 6.06% +1.160 pp 1.64% -0.114 pp USD27.09 +3.3% 7 qtrs
5 STATE STREET CORP 9.47M +932.5K (+10.9%) 265.05M +8.8M (+3.5%) 5.74% +0.561 pp 0.01% +0.000 pp USD30.45 -8.1% 51 qtrs
6 PRICE T ROWE ASSOCIATES INC /MD/ 9.00M -1.2M (-12.1%) 251.79M -55.4M (-18.0%) 5.45% -0.756 pp 0.03% -0.006 pp USD26.45 +5.8% 58 qtrs
7 RENAISSANCE TECHNOLOGIES LLC 6.67M +375.5K (+6.0%) 186.57M -2.2M (-1.2%) 4.04% +0.225 pp 0.29% +0.040 pp USD25.78 +8.5% 32 qtrs
8 AMERICAN CENTURY COMPANIES INC 5.96M +1.6M (+35.5%) 166.67M +34.7M (+26.3%) 3.61% +0.943 pp 0.08% +0.017 pp USD28.00 -0.1% 18 qtrs
9 JPMORGAN CHASE & CO 5.18M +1.3M (+32.0%) 145.06M +27.2M (+23.1%) 3.14% +0.759 pp 0.01% +0.002 pp USD31.20 -10.3% 16 qtrs
10 DIMENSIONAL FUND ADVISORS LP 4.41M +714.8K (+19.3%) 123.47M +12.5M (+11.3%) 2.67% +0.431 pp 0.03% +0.002 pp USD26.46 +5.7% 51 qtrs
11 GEODE CAPITAL MANAGEMENT, LLC 4.08M +19.4K (+0.5%) 114.20M -7.7M (-6.3%) 2.47% +0.010 pp 0.01% -0.001 pp USD29.35 -4.7% 57 qtrs
12 COMMODORE CAPITAL LP 3.55M +453.2K (+14.6%) 99.33M +6.4M (+6.9%) 2.15% +0.273 pp 6.61% +2.077 pp USD27.50 +1.7% 7 qtrs
13 WELLINGTON MANAGEMENT GROUP LLP 3.02M +2.6M (+705.0%) 84.51M +73.3M (+650.8%) 1.83% +1.602 pp 0.01% +0.013 pp USD27.83 +0.5% 57 qtrs
14 PRIMECAP MANAGEMENT CO/CA/ 2.56M -194.8K (-7.1%) 71.75M -11.0M (-13.3%) 1.55% -0.119 pp 0.05% -0.009 pp USD53.54 -47.7% 39 qtrs
15 UBS GROUP AG 2.54M +1.8M (+237.4%) 71.21M +48.6M (+214.7%) 1.54% +1.084 pp 0.01% +0.008 pp USD29.29 -4.5% 45 qtrs
16 NUVEEN, LLC 2.43M +253.6K (+11.7%) 67.91M +2.7M (+4.1%) 1.47% +0.153 pp 0.02% +0.001 pp USD32.29 -13.3% 4 qtrs
17 GOLDMAN SACHS GROUP INC 2.27M +272.6K (+13.7%) 63.45M +3.6M (+6.0%) 1.37% +0.164 pp 0.01% +0.001 pp USD29.14 -4.0% 57 qtrs
18 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 2.15M +12.4K (+0.6%) 60.23M -4.0M (-6.2%) 1.30% +0.007 pp 0.01% -0.001 pp USD29.92 -6.5% 57 qtrs
19 DEEP TRACK CAPITAL, LP 2.00M +2.0M (+100.0%) 55.96M +56.0M (+100.0%) 1.21% +1.212 pp 1.00% +0.998 pp USD27.98 +0.0% 1 qtrs NEW
20 NORGES BANK 1.95M +1.9M (+100.0%) 54.44M +54.4M (+100.0%) 1.18% +1.179 pp 0.01% +0.006 pp USD27.98 +0.0% 1 qtrs NEW
21 LOOMIS SAYLES & CO L P 1.90M -146.3K (-7.1%) 53.23M -8.2M (-13.4%) 1.15% -0.090 pp 0.06% -0.009 pp USD28.44 -1.6% 12 qtrs
22 MORGAN STANLEY 1.89M +337.0K (+21.7%) 52.84M +6.3M (+13.5%) 1.14% +0.203 pp 0.00% +0.000 pp USD28.48 -1.8% 51 qtrs
23 RTW INVESTMENTS, LP 1.67M +— (+0.0%) 46.79M -3.4M (-6.7%) 1.01% -0.001 pp 0.47% -0.150 pp USD27.34 +2.3% 10 qtrs
24 NORTHERN TRUST CORP 1.65M -112.7K (-6.4%) 46.26M -6.7M (-12.7%) 1.00% -0.069 pp 0.01% -0.001 pp USD29.89 -6.4% 51 qtrs
25 PICTET ASSET MANAGEMENT HOLDING SA 1.48M +584.2K (+65.4%) 41.34M +14.8M (+55.6%) 0.89% +0.353 pp 0.04% +0.015 pp USD28.84 -3.0% 10 qtrs
26 FIRST TRUST ADVISORS LP 1.45M +56.0K (+4.0%) 40.68M -1.3M (-3.0%) 0.88% +0.033 pp 0.03% -0.002 pp USD32.17 -13.0% 50 qtrs
27 ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.45M +241.9K (+20.0%) 40.59M +4.3M (+11.9%) 0.88% +0.146 pp 0.02% +0.001 pp USD29.56 -5.3% 3 qtrs
28 AVORO CAPITAL ADVISORS LLC 1.40M -840.0K (-37.5%) 39.17M -28.0M (-41.7%) 0.85% -0.510 pp 0.38% -0.492 pp USD28.74 -2.6% 5 qtrs
29 FMR LLC 1.36M +59.8K (+4.6%) 37.92M -944.8K (-2.4%) 0.82% +0.036 pp 0.00% 0.000 pp USD31.74 -11.8% 17 qtrs
30 ARTISAN PARTNERS LIMITED PARTNERSHIP 1.35M -760.7K (-36.1%) 37.75M -25.5M (-40.4%) 0.82% -0.462 pp 0.06% -0.033 pp USD22.57 +24.0% 24 qtrs
31 BANK OF AMERICA CORP /DE/ 1.33M +236.7K (+21.6%) 37.30M +4.4M (+13.4%) 0.81% +0.143 pp 0.00% +0.001 pp USD30.24 -7.5% 52 qtrs
32 SOLEUS CAPITAL MANAGEMENT, L.P. 1.32M +1.3M (+100.0%) 37.00M +37.0M (+100.0%) 0.80% +0.801 pp 1.36% +1.365 pp USD27.98 +0.0% 1 qtrs NEW
33 TWO SIGMA INVESTMENTS, LP 1.21M +556.9K (+84.8%) 33.95M +14.3M (+72.4%) 0.74% +0.337 pp 0.05% +0.019 pp USD29.10 -3.8% 41 qtrs
34 CITADEL ADVISORS LLC 1.20M +493.4K (+70.0%) 33.53M +12.4M (+58.6%) 0.73% +0.299 pp 0.01% +0.002 pp USD29.10 -3.8% 32 qtrs
35 SQUAREPOINT OPS LLC 1.10M +650.5K (+146.1%) 30.66M +17.3M (+129.5%) 0.66% +0.394 pp 0.03% +0.019 pp USD28.72 -2.6% 34 qtrs
36 BANK OF NEW YORK MELLON CORP 1.07M -350.4K (-24.6%) 30.05M -12.7M (-29.7%) 0.65% -0.213 pp 0.01% -0.003 pp USD25.53 +9.6% 57 qtrs
37 AFFINITY ASSET ADVISORS, LLC 1.00M -250.0K (-20.0%) 27.98M -9.5M (-25.4%) 0.61% -0.152 pp 1.59% -1.672 pp USD26.93 +3.9% 10 qtrs
38 VIRGINIA RETIREMENT SYSTEMS ET AL 976.5K +75.2K (+8.3%) 27.32M +282.0K (+1.0%) 0.59% +0.045 pp 0.16% -0.013 pp USD29.84 -6.2% 4 qtrs
39 PRINCIPAL FINANCIAL GROUP INC 947.6K +47.3K (+5.3%) 26.51M -495.4K (-1.8%) 0.57% +0.028 pp 0.01% 0.000 pp USD27.60 +1.4% 57 qtrs
40 PANAGORA ASSET MANAGEMENT INC 929.0K +41.8K (+4.7%) 25.99M -623.5K (-2.3%) 0.56% +0.025 pp 0.09% -0.015 pp USD25.71 +8.8% 58 qtrs
41 D. E. SHAW & CO., INC. 911.3K +382.5K (+72.3%) 25.50M +9.6M (+60.7%) 0.55% +0.232 pp 0.01% +0.005 pp USD28.22 -0.9% 52 qtrs
42 DRIEHAUS CAPITAL MANAGEMENT LLC 797.0K -30.5K (-3.7%) 22.30M -2.5M (-10.2%) 0.48% -0.019 pp 0.15% -0.026 pp USD32.84 -14.8% 4 qtrs
43 FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 700.6K +— (+0.0%) 19.60M -1.4M (-6.7%) 0.42% 0.000 pp 0.53% -0.103 pp USD28.26 -1.0% 6 qtrs
44 BALYASNY ASSET MANAGEMENT L.P. 679.6K +679.6K (+100.0%) 19.02M +19.0M (+100.0%) 0.41% +0.412 pp 0.02% +0.024 pp USD27.98 +0.0% 1 qtrs NEW
45 PACER ADVISORS, INC. 674.9K -133.3K (-16.5%) 18.88M -5.4M (-22.1%) 0.41% -0.081 pp 0.05% -0.013 pp USD26.59 +5.2% 9 qtrs
46 PUBLIC SECTOR PENSION INVESTMENT BOARD 671.2K -39.5K (-5.6%) 18.78M -2.5M (-11.9%) 0.41% -0.024 pp 0.06% -0.015 pp USD29.33 -4.6% 9 qtrs
47 SEGALL BRYANT & HAMILL, LLC 615.3K +18.8K (+3.2%) 17.22M -678.5K (-3.8%) 0.37% +0.011 pp 0.23% -0.005 pp USD24.45 +14.4% 24 qtrs
48 BARCLAYS PLC 565.0K +141.1K (+33.3%) 15.81M +3.9M (+33.2%) 0.34% +0.085 pp 0.00% +0.001 pp USD27.64 +1.2% 51 qtrs
49 TWO SIGMA ADVISERS, LP 562.6K +357.4K (+174.2%) 15.74M +9.6M (+155.7%) 0.34% +0.216 pp 0.03% +0.018 pp USD28.75 -2.7% 41 qtrs
50 WOODLINE PARTNERS LP 558.6K +— (+0.0%) 15.63M -1.1M (-6.7%) 0.34% 0.000 pp 0.06% -0.018 pp USD28.02 -0.1% 10 qtrs
51 INVESCO LTD. 538.7K -45.6K (-7.8%) 15.07M -2.5M (-14.0%) 0.33% -0.028 pp 0.00% -0.001 pp USD25.04 +11.7% 57 qtrs
52 AMERIPRISE FINANCIAL INC 531.4K -26.5K (-4.8%) 14.87M -1.9M (-11.2%) 0.32% -0.016 pp 0.00% -0.001 pp USD28.45 -1.7% 55 qtrs
53 METLIFE INVESTMENT MANAGEMENT, LLC 530.4K -176.8K (-25.0%) 14.84M -6.4M (-30.1%) 0.32% -0.107 pp 0.07% -0.030 pp USD31.18 -10.3% 19 qtrs
54 ACADIAN ASSET MANAGEMENT LLC 522.1K -46.6K (-8.2%) 14.60M -2.4M (-14.4%) 0.32% -0.029 pp 0.02% -0.006 pp USD32.83 -14.8% 27 qtrs
55 AQR CAPITAL MANAGEMENT LLC 514.3K +141.9K (+38.1%) 14.39M +3.2M (+28.8%) 0.31% +0.086 pp 0.01% +0.000 pp USD26.51 +5.5% 35 qtrs
56 VOYA INVESTMENT MANAGEMENT LLC 501.8K -31.8K (-6.0%) 14.04M -2.0M (-12.3%) 0.30% -0.020 pp 0.01% -0.002 pp USD26.22 +6.7% 51 qtrs
57 OPALEYE MANAGEMENT INC. 490.0K +40.0K (+8.9%) 13.71M +210.2K (+1.6%) 0.30% +0.024 pp 1.81% -0.100 pp USD29.84 -6.2% 2 qtrs
58 RHUMBLINE ADVISERS 439.2K -34.6K (-7.3%) 12.29M -1.9M (-13.6%) 0.27% -0.021 pp 0.01% -0.002 pp USD29.06 -3.7% 51 qtrs
59 BNP PARIBAS ARBITRAGE, SNC 430.3K -330.9K (-43.5%) 12.04M -10.8M (-47.3%) 0.26% -0.201 pp 0.01% -0.007 pp USD28.57 -2.1% 46 qtrs
60 LEGAL & GENERAL GROUP PLC 429.5K -70.1K (-14.0%) 12.02M -3.0M (-19.8%) 0.26% -0.043 pp 0.00% -0.001 pp USD34.20 -18.2% 37 qtrs
61 GLENMEDE TRUST CO NA 412.9K +412.9K (+100.0%) 11.55M +11.6M (+100.0%) 0.25% +0.250 pp 0.05% +0.055 pp USD27.98 +0.0% 1 qtrs NEW
62 VICTORY CAPITAL MANAGEMENT INC 402.6K +58.4K (+17.0%) 11.26M +938.1K (+9.1%) 0.24% +0.035 pp 0.01% +0.000 pp USD29.07 -3.7% 26 qtrs
63 UBS ASSET MANAGEMENT AMERICAS INC 394.9K +2.4K (+0.6%) 11.05M -724.8K (-6.2%) 0.24% +0.001 pp 0.00% 0.000 pp USD27.11 +3.2% 58 qtrs
64 FISHER ASSET MANAGEMENT, LLC 390.5K +67.7K (+21.0%) 10.93M +1.2M (+12.8%) 0.24% +0.041 pp 0.00% +0.000 pp USD28.41 -1.5% 47 qtrs
65 RICE HALL JAMES & ASSOCIATES, LLC 379.5K -5.9K (-1.5%) 10.62M -943.0K (-8.2%) 0.23% -0.004 pp 0.58% -0.046 pp USD26.85 +4.2% 9 qtrs
66 ALLIANZ ASSET MANAGEMENT GMBH 347.3K -177.5K (-33.8%) 9.72M -6.0M (-38.3%) 0.21% -0.108 pp 0.01% -0.008 pp USD29.90 -6.4% 8 qtrs
67 BRIDGEWATER ASSOCIATES, LP 344.5K +344.5K (+100.0%) 9.64M +9.6M (+100.0%) 0.21% +0.209 pp 0.04% +0.035 pp USD27.98 +0.0% 1 qtrs NEW
68 RAYMOND JAMES FINANCIAL INC 328.2K -118.7K (-26.6%) 9.14M -4.3M (-31.8%) 0.20% -0.072 pp 0.00% -0.002 pp USD28.77 -2.7% 5 qtrs
69 ROYAL BANK OF CANADA 325.5K -93.8K (-22.4%) 9.11M -3.5M (-27.6%) 0.20% -0.057 pp 0.00% -0.001 pp USD30.41 -8.0% 51 qtrs
70 CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 324.6K +3.7K (+1.2%) 9.08M -544.7K (-5.7%) 0.20% +0.002 pp 0.01% -0.001 pp USD28.13 -0.5% 53 qtrs
71 MAN GROUP PLC 312.5K -584.8K (-65.2%) 8.74M -18.2M (-67.5%) 0.19% -0.355 pp 0.01% -0.032 pp USD29.62 -5.5% 32 qtrs
72 CANADA PENSION PLAN INVESTMENT BOARD 310.6K -105.2K (-25.3%) 8.69M -3.8M (-30.3%) 0.19% -0.064 pp 0.01% -0.003 pp USD28.32 -1.2% 15 qtrs
73 SWISS NATIONAL BANK 309.2K +5.6K (+1.8%) 8.65M -456.6K (-5.0%) 0.19% +0.003 pp 0.01% 0.000 pp USD38.18 -26.7% 51 qtrs
74 EDGESTREAM PARTNERS, L.P. 291.3K +31.9K (+12.3%) 8.15M +368.2K (+4.7%) 0.18% +0.019 pp 0.23% +0.002 pp USD29.91 -6.5% 17 qtrs
75 ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. 285.7K +151.3K (+112.6%) 7.99M +4.0M (+98.3%) 0.17% +0.092 pp 0.01% +0.006 pp USD28.17 -0.7% 10 qtrs
76 QUBE RESEARCH & TECHNOLOGIES LTD 276.6K +276.6K (+100.0%) 7.74M +7.7M (+100.0%) 0.17% +0.168 pp 0.01% +0.008 pp USD27.98 +0.0% 1 qtrs NEW
77 VOLORIDGE INVESTMENT MANAGEMENT, LLC 273.2K +8.7K (+3.3%) 7.64M -290.4K (-3.7%) 0.17% +0.005 pp 0.03% +0.000 pp USD29.03 -3.6% 10 qtrs
78 PEREGRINE CAPITAL MANAGEMENT LLC 254.3K -3.5K (-1.3%) 7.12M -617.6K (-8.0%) 0.15% -0.002 pp 0.22% -0.015 pp USD28.61 -2.2% 3 qtrs
79 C WORLDWIDE GROUP HOLDING A/S 250.0K +— (+0.0%) 7.00M -505.0K (-6.7%) 0.15% 0.000 pp 0.12% +0.007 pp USD28.76 -2.7% 5 qtrs
80 PALO ALTO INVESTORS LP 242.6K +58.6K (+31.9%) 6.79M +1.3M (+23.0%) 0.15% +0.035 pp 0.94% -0.076 pp USD23.13 +21.0% 21 qtrs
81 HEALTHINVEST PARTNERS AB 242.5K -10.4K (-4.1%) 6.78M +6.0M (+742.4%) 0.15% -0.006 pp 2.16% -0.822 pp USD27.51 +1.7% 7 qtrs
82 BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 241.1K +239.4K (+13,469.7%) 6.75M +6.7M (+12,628.3%) 0.15% +0.145 pp 0.01% +0.008 pp USD27.98 +0.0% 3 qtrs
83 WELLS FARGO & COMPANY/MN 233.0K +100.4K (+75.7%) 6.52M +2.5M (+63.9%) 0.14% +0.061 pp 0.00% +0.000 pp USD28.33 -1.2% 57 qtrs
84 FCF ADVISORS LLC 219.5K +219.5K (+100.0%) 6.14M +6.1M (+100.0%) 0.13% +0.133 pp 0.80% +0.802 pp USD27.98 +0.0% 1 qtrs NEW
85 ALLIANCEBERNSTEIN L.P. 215.9K -22.7K (-9.5%) 6.04M -1.1M (-15.6%) 0.13% -0.014 pp 0.00% 0.000 pp USD28.15 -0.6% 57 qtrs
86 RAFFERTY ASSET MANAGEMENT, LLC 203.3K +23.4K (+13.0%) 5.69M +290.3K (+5.4%) 0.12% +0.014 pp 0.02% +0.002 pp USD25.21 +11.0% 28 qtrs
87 S&CO INC 201.8K +550.0 (+0.3%) 5.65M -391.0K (-6.5%) 0.12% +0.000 pp 0.35% -0.019 pp USD22.67 +23.4% 52 qtrs
88 HRT FINANCIAL LP 200.2K +181.9K (+995.5%) 5.60M +5.1M (+922.3%) 0.12% +0.110 pp 0.02% +0.016 pp USD28.16 -0.6% 6 qtrs
89 PRUDENTIAL FINANCIAL INC 194.5K -15.3K (-7.3%) 5.44M -852.5K (-13.5%) 0.12% -0.009 pp 0.01% -0.001 pp USD28.49 -1.8% 19 qtrs
90 UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 194.5K +55.4K (+39.8%) 5.44M +1.3M (+30.3%) 0.12% +0.034 pp 0.01% +0.002 pp USD29.13 -3.9% 5 qtrs
91 FRANKLIN RESOURCES INC 192.8K +8.5K (+4.6%) 5.39M -135.6K (-2.5%) 0.12% +0.005 pp 0.00% 0.000 pp USD28.83 -2.9% 18 qtrs
92 SEI INVESTMENTS CO 190.7K -35.1K (-15.5%) 5.34M -1.4M (-21.2%) 0.12% -0.021 pp 0.01% -0.002 pp USD31.36 -10.8% 45 qtrs
93 WEDGE CAPITAL MANAGEMENT L L P/NC 172.3K +31.2K (+22.1%) 4.82M +586.9K (+13.9%) 0.10% +0.019 pp 0.09% +0.015 pp USD26.04 +7.5% 7 qtrs
94 MARTINGALE ASSET MANAGEMENT L P 170.3K +5.2K (+3.1%) 4.76M -189.2K (-3.8%) 0.10% +0.003 pp 0.12% -0.004 pp USD28.59 -2.1% 18 qtrs
95 INTECH INVESTMENT MANAGEMENT LLC 159.6K +85.5K (+115.5%) 4.47M +2.2M (+101.0%) 0.10% +0.052 pp 0.04% +0.020 pp USD28.53 -1.9% 6 qtrs
96 BESSEMER GROUP INC 157.6K +155.4K (+6,994.5%) 4.41M +4.3M (+6,482.1%) 0.10% +0.094 pp 0.01% +0.007 pp USD28.00 -0.1% 8 qtrs
97 RUSSELL INVESTMENTS GROUP, LTD. 157.4K -22.1K (-12.3%) 4.39M -888.7K (-16.8%) 0.10% -0.014 pp 0.00% -0.001 pp USD32.21 -13.1% 37 qtrs
98 NEUBERGER BERMAN GROUP LLC 152.8K +51.0 (+0.0%) 4.27M -307.1K (-6.7%) 0.09% +0.000 pp 0.00% 0.000 pp USD32.72 -14.5% 11 qtrs
99 CAPITAL FUND MANAGEMENT S.A. 150.8K +29.8K (+24.6%) 4.22M +589.9K (+16.3%) 0.09% +0.018 pp 0.01% +0.002 pp USD29.23 -4.3% 16 qtrs
Ownership breakdown by holder

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.38
Bearish
Ratio by volume
0.37
Bearish
Buys
3
Sells
8
Shares acquired
13.8K
Shares disposed
36.7K
Cash buys
Cash sales
4.00
Net activity
-22,969
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-05-04 Gaffin David Joseph Officer S-Sale D Ordinary Shares 2,034 33.20 67.5K 231,558 D
2026-05-01 Hopkinson Craig C. Officer M-Exempt A Ordinary Shares 5,000 19.34 96.7K 90,389 D
2026-04-11 Lurker Nancy Director M-Exempt A Ordinary Shares 3,751 0.00 14,456 D
2026-04-06 Gaffin David Joseph Officer S-Sale D Ordinary Shares 2,034 34.57 70.3K 233,592 D
2026-04-01 Hopkinson Craig C. Officer M-Exempt D Employee Stock Option (Right to Buy) 5,000 19.34 96.7K 16,356 D
2026-03-03 Gaffin David Joseph Officer S-Sale D Ordinary Shares 2,034 29.76 60.5K 235,626 D
2026-03-02 Reed Joshua Officer A-Award A Restricted Stock Unit Award 30,854 0.00 30,854 D
2026-03-02 Parisi Samuel Joseph Officer S-Sale D Ordinary Shares 6,890 29.29 201.8K 7,717 D
2026-03-02 POPS RICHARD F Director / Officer A-Award A Restricted Stock Unit Award 88,843 0.00 88,843 D
2026-03-02 Nichols Christian Todd Officer A-Award A Employee Stock Option (Right to Buy) 66,430 30.25 2.01M 66,430 D
2026-03-02 Jackson Blair Curtis Officer A-Award A Restricted Stock Unit Award 44,078 0.00 44,078 D
2026-03-02 Hopkinson Craig C. Officer M-Exempt D Employee Stock Option (Right to Buy) 5,000 19.34 96.7K 21,356 D
2026-03-02 Gaffin David Joseph Officer A-Award A Restricted Stock Unit Award 36,364 0.00 36,364 D
2026-02-26 Parisi Samuel Joseph Officer M-Exempt D Restricted Stock Unit Award 2,747 0.00 5,493 D
2026-02-26 Nichols Christian Todd Officer M-Exempt D Restricted Stock Unit Award 5,410 0.00 10,819 D
2026-02-26 Jackson Blair Curtis Officer F-InKind D Ordinary Shares 3,695 30.73 113.5K 241,308 D
2026-02-26 Hopkinson Craig C. Officer M-Exempt D Restricted Stock Unit Award 6,866 0.00 13,732 D
2026-02-26 Gaffin David Joseph Officer M-Exempt D Restricted Stock Unit Award 6,866 0.00 13,732 D
2026-02-23 Parisi Samuel Joseph Officer M-Exempt D Restricted Stock Unit Award 2,283 0.00 2,284 D
2026-02-23 Nichols Christian Todd Officer F-InKind D Ordinary Shares 2,845 32.19 91.6K 112,762 D
2026-02-23 Jackson Blair Curtis Officer F-InKind D Ordinary Shares 3,880 32.19 124.9K 236,681 D
2026-02-23 Hopkinson Craig C. Officer M-Exempt D Restricted Stock Unit Award 7,689 0.00 7,690 D
2026-02-23 Gaffin David Joseph Officer M-Exempt D Restricted Stock Unit Award 7,689 0.00 7,690 D
2026-02-19 Parisi Samuel Joseph Officer M-Exempt D Restricted Stock Unit Award 2,991 0.00 8,974 D
2026-02-19 Nichols Christian Todd Officer F-InKind D Ordinary Shares 2,277 32.00 72.9K 109,200 D
2026-02-19 Jackson Blair Curtis Officer M-Exempt D Restricted Stock Unit Award 9,300 0.00 27,903 D
2026-02-19 Hopkinson Craig C. Officer M-Exempt D Restricted Stock Unit Award 7,673 0.00 23,019 D
2026-02-19 Gaffin David Joseph Officer M-Exempt A Ordinary Shares 7,673 0.00 235,009 D
2026-02-18 Parisi Samuel Joseph Officer M-Exempt D Restricted Stock Unit Award 2,034 0.00 0 D
2026-02-18 Nichols Christian Todd Officer M-Exempt D Restricted Stock Unit Award 6,355 0.00 0 D
2026-02-18 Jackson Blair Curtis Officer M-Exempt D Restricted Stock Unit Award 8,897 0.00 0 D
2026-02-18 Hopkinson Craig C. Officer M-Exempt D Restricted Stock Unit Award 8,897 0.00 0 D
2026-02-18 Gaffin David Joseph Officer M-Exempt A Ordinary Shares 6,355 0.00 229,462 D
2026-02-05 POPS RICHARD F Director / Officer F-InKind D Ordinary Shares 62,230 33.55 2.09M 1,377,740 D
2026-02-05 Nichols Christian Todd Officer F-InKind D Ordinary Shares 6,389 33.55 214.4K 100,946 D
2026-02-05 Jackson Blair Curtis Officer F-InKind D Ordinary Shares 8,626 33.55 289.4K 221,552 D
2026-02-05 Hopkinson Craig C. Officer F-InKind D Ordinary Shares 7,454 33.55 250.1K 75,638 D
2026-02-05 Gaffin David Joseph Officer F-InKind D Ordinary Shares 7,619 33.55 255.6K 223,107 D
2026-02-02 Hopkinson Craig C. Officer S-Sale D Ordinary Shares 5,000 34.24 171.2K 61,740 D
2026-02-02 Cooke Shane Director M-Exempt A Ordinary Shares 61,200 31.64 1.94M 164,944 D
2026-01-08 Hopkinson Craig C. Officer M-Exempt A Ordinary Shares 5,000 19.34 96.7K 66,740 D
2026-01-02 Hopkinson Craig C. Officer S-Sale D Ordinary Shares 4,000 28.00 112.0K 61,740 D
2025-12-03 Hopkinson Craig C. Officer M-Exempt D Employee Stock Option (Right to Buy) 3,748 19.34 72.5K 36,356 D
2025-12-01 Hopkinson Craig C. Officer S-Sale D Ordinary Shares 4,000 29.30 117.2K 65,740 D
2025-11-03 Hopkinson Craig C. Officer M-Exempt A Ordinary Shares 5,000 19.34 96.7K 78,740 D
2025-10-15 Hopkinson Craig C. Officer M-Exempt A Ordinary Shares 5,000 19.34 96.7K 82,740 D
2025-10-08 Reed Joshua Officer A-Award A Restricted Stock Unit Award 36,656 0.00 36,656 D
2025-09-15 Reed Joshua Officer 0 0.00 0
2025-08-03 Gaffin David Joseph Officer M-Exempt A Ordinary Shares 2,014 0.00 206,269 D
2025-06-10 Nichols Christian Todd Officer S-Sale D Ordinary Shares 3,334 31.09 103.7K 86,208 D
2025-06-09 Nichols Christian Todd Officer S-Sale D Ordinary Shares 3,333 31.95 106.5K 89,542 D
2025-06-08 Wright Christopher I Director M-Exempt A Ordinary Shares 3,301 0.00 23,806 D
2025-05-31 snyderman nancy lynn MD Director M-Exempt D Restricted Stock Unit Award 8,013 0.00 0 D
2025-05-31 Wright Christopher I Director M-Exempt D Restricted Stock Unit Award 8,013 0.00 0 D
2025-05-31 Wilson Frank Anders Director M-Exempt D Restricted Stock Unit Award 8,013 0.00 0 D
2025-05-31 MCKEON BRIAN P Director F-InKind D Ordinary Shares 1,924 30.61 58.9K 33,869 D
2025-05-31 Lurker Nancy Director M-Exempt D Restricted Stock Unit Award 8,013 0.00 0 D
2025-05-31 LAURENCIN CATO T Director M-Exempt A Ordinary Shares 8,013 0.00 31,026 D
2025-05-31 GAYNOR RICHARD Director M-Exempt A Ordinary Shares 8,013 0.00 33,008 D
2025-05-31 Cooke Shane Director F-InKind D Ordinary Shares 4,175 30.61 127.8K 103,744 D
2025-05-21 snyderman nancy lynn MD Director A-Award A Restricted Stock Unit Award 6,142 0.00 6,142 D
2025-05-21 Wright Christopher I Director A-Award A Restricted Stock Unit Award 6,142 0.00 6,142 D
2025-05-21 Wilson Frank Anders Director A-Award A Restricted Stock Unit Award 6,142 0.00 6,142 D
2025-05-21 MCKEON BRIAN P Director A-Award A Restricted Stock Unit Award 6,142 0.00 6,142 D
2025-05-21 Lurker Nancy Director A-Award A Non Qualified Stock Option (Right to Buy) 13,474 30.53 411.4K 13,474 D
2025-05-21 LAURENCIN CATO T Director A-Award A Non Qualified Stock Option (Right to Buy) 13,474 30.53 411.4K 13,474 D
2025-05-21 GAYNOR RICHARD Director A-Award A Non Qualified Stock Option (Right to Buy) 13,474 30.53 411.4K 13,474 D
2025-05-21 Cooke Shane Director A-Award A Non Qualified Stock Option (Right to Buy) 13,474 30.53 411.4K 13,474 D
2025-04-11 Lurker Nancy Director F-InKind D Ordinary Shares 901 27.00 24.3K 4,616 D
2025-02-28 Parisi Samuel Joseph Officer S-Sale D Ordinary Shares 1,938 34.00 65.9K 7,717 D
2025-02-26 Parisi Samuel Joseph Officer M-Exempt D Restricted Stock Unit Award 2,746 0.00 8,240 D
2025-02-26 Nichols Christian Todd Officer M-Exempt D Restricted Stock Unit Award 5,409 0.00 16,229 D
2025-02-26 Jackson Blair Curtis Officer M-Exempt D Restricted Stock Unit Award 8,322 0.00 24,967 D
2025-02-26 Hopkinson Craig C. Officer M-Exempt D Restricted Stock Unit Award 6,866 0.00 20,598 D
2025-02-26 Gaffin David Joseph Officer M-Exempt D Restricted Stock Unit Award 6,866 0.00 20,598 D
2025-02-26 Brown Iain Michael Officer M-Exempt D Restricted Stock Unit Award 5,617 0.00 16,854 D
2025-02-25 Parisi Samuel Joseph Officer S-Sale D Ordinary Shares 3,743 35.26 132.0K 7,717 D
2025-02-23 Parisi Samuel Joseph Officer M-Exempt A Ordinary Shares 2,284 0.00 12,132 D
2025-02-23 Nichols Christian Todd Officer M-Exempt D Restricted Stock Unit Award 6,408 0.00 12,815 D
2025-02-23 Jackson Blair Curtis Officer M-Exempt D Restricted Stock Unit Award 8,738 0.00 17,476 D
2025-02-23 Hopkinson Craig C. Officer M-Exempt A Ordinary Shares 7,689 0.00 77,337 D
2025-02-23 Gaffin David Joseph Officer M-Exempt D Restricted Stock Unit Award 7,689 0.00 15,379 D
2025-02-23 Brown Iain Michael Officer F-InKind D Ordinary Shares 2,587 35.32 91.4K 145,073 D
2025-02-22 Parisi Samuel Joseph Officer M-Exempt A Ordinary Shares 3,114 0.00 10,831 D
2025-02-22 Nichols Christian Todd Officer M-Exempt D Restricted Stock Unit Award 7,109 0.00 0 D
2025-02-22 Jackson Blair Curtis Officer M-Exempt D Restricted Stock Unit Award 9,694 0.00 0 D
2025-02-22 Hopkinson Craig C. Officer M-Exempt A Ordinary Shares 12,279 0.00 75,100 D
2025-02-22 Gaffin David Joseph Officer M-Exempt A Ordinary Shares 7,432 0.00 199,463 D
2025-02-22 Brown Iain Michael Officer M-Exempt D Restricted Stock Unit Award 7,109 0.00 0 D
2025-02-20 Parisi Samuel Joseph Officer S-Sale D Ordinary Shares 1,327 35.69 47.4K 7,717 D
2025-02-19 Parisi Samuel Joseph Officer A-Award A Employee Stock Option (Right to Buy) 12,287 35.84 440.4K 12,287 D
2025-02-19 POPS RICHARD F Director / Officer A-Award A Employee Stock Option (Right to Buy) 293,921 35.84 10.53M 293,921 D
2025-02-19 Nichols Christian Todd Officer A-Award A Restricted Stock Unit Award 24,182 0.00 24,182 D
2025-02-19 Jackson Blair Curtis Officer A-Award A Employee Stock Option (Right to Buy) 77,565 35.84 2.78M 77,565 D
2025-02-19 Hopkinson Craig C. Officer A-Award A Employee Stock Option (Right to Buy) 63,991 35.84 2.29M 63,991 D
2025-02-19 Gaffin David Joseph Officer A-Award A Restricted Stock Unit Award 30,692 0.00 30,692 D
2025-02-18 Parisi Samuel Joseph Officer M-Exempt A Ordinary Shares 2,033 0.00 9,750 D
2025-02-18 Nichols Christian Todd Officer F-InKind D Ordinary Shares 1,869 35.90 67.1K 82,354 D
2025-02-18 Jackson Blair Curtis Officer F-InKind D Ordinary Shares 3,950 35.90 141.8K 186,494 D
2025-02-18 Hopkinson Craig C. Officer M-Exempt D Restricted Stock Unit Award 8,896 0.00 8,897 D
2025-02-18 Gaffin David Joseph Officer M-Exempt D Restricted Stock Unit Award 6,354 0.00 6,355 D
2025-02-18 Brown Iain Michael Officer M-Exempt D Restricted Stock Unit Award 6,354 0.00 6,355 D
2025-02-13 Hopkinson Craig C. Officer S-Sale D Ordinary Shares 35,586 34.02 1.21M 166,708 D
2025-02-12 Hopkinson Craig C. Officer M-Exempt D Employee Stock Option (Right to Buy) 111,630 19.34 2.16M 50,104 D
2025-02-06 POPS RICHARD F Director / Officer F-InKind D Ordinary Shares 79,925 31.39 2.51M 1,290,390 D
2025-02-06 Nichols Christian Todd Officer F-InKind D Ordinary Shares 7,399 31.39 232.3K 77,869 D
2025-02-06 Jackson Blair Curtis Officer F-InKind D Ordinary Shares 10,647 31.39 334.2K 181,548 D
2025-02-06 Hopkinson Craig C. Officer A-Award A Ordinary Shares 34,393 0.00 78,683 D
2025-02-06 Gaffin David Joseph Officer F-InKind D Ordinary Shares 9,752 31.39 306.1K 188,499 D
2025-02-06 Brown Iain Michael Officer F-InKind D Ordinary Shares 7,514 31.39 235.9K 133,395 D
2025-01-30 Hopkinson Craig C. Officer S-Sale D Ordinary Shares 100,918 32.05 3.23M 44,290 D
2024-12-09 LAURENCIN CATO T Director M-Exempt D Non Qualified Stock Option (Right to Buy) 2,691 22.52 60.6K 16,142 D
2024-12-09 Hopkinson Craig C. Officer M-Exempt A Ordinary Shares 12,090 19.34 233.8K 84,272 D
2024-12-08 LAURENCIN CATO T Director M-Exempt A Ordinary Shares 4,163 0.00 23,971 D
2024-12-05 Hopkinson Craig C. Officer S-Sale D Ordinary Shares 9,221 31.50 290.5K 59,730 D
2024-12-04 Hopkinson Craig C. Officer S-Sale D Ordinary Shares 14,349 30.77 441.6K 68,951 D
2024-11-27 Nichols Christian Todd Officer S-Sale D Ordinary Shares 5,208 29.15 151.8K 60,703 D
2024-11-11 Hopkinson Craig C. Officer M-Exempt A Ordinary Shares 43,058 20.03 862.5K 142,296 D
2024-11-06 Hopkinson Craig C. Officer S-Sale D Ordinary Shares 10,471 29.53 309.2K 99,238 D
2024-08-03 Gaffin David Joseph Officer M-Exempt A Ordinary Shares 2,014 0.00 166,796
2024-06-29 snyderman nancy lynn MD Director M-Exempt A Ordinary Shares 6,104 0.00 6,104
2024-06-29 Wright Christopher I Director M-Exempt A Ordinary Shares 6,104 0.00 15,881
2024-06-29 Wilson Frank Anders Director M-Exempt D Restricted Stock Unit Award 6,104 0.00 0
2024-06-29 MCKEON BRIAN P Director M-Exempt D Restricted Stock Unit Award 6,104 0.00 0
2024-06-29 LAURENCIN CATO T Director F-InKind D Ordinary Shares 1,465 24.10 35.3K 19,808
2024-06-29 GAYNOR RICHARD Director M-Exempt A Ordinary Shares 6,104 0.00 26,460
2024-06-29 Daglio David Angelo Jr. Director F-InKind D Ordinary Shares 1,465 24.10 35.3K 27,780
2024-06-29 Cooke Shane Director M-Exempt A Ordinary Shares 6,104 0.00 103,081
2024-06-29 Alva Emily Peterson Director F-InKind D Ordinary Shares 1,465 24.10 35.3K 27,302
2024-06-09 Alva Emily Peterson Director M-Exempt A Ordinary Shares 3,871 0.00 23,593
2024-06-08 Wright Christopher I Director F-InKind D Ordinary Shares 793 23.91 19.0K 9,777
2024-05-31 snyderman nancy lynn MD Director A-Award A Restricted Stock Unit Award 8,013 0.00 8,013
2024-05-31 Wright Christopher I Director A-Award A Restricted Stock Unit Award 8,013 0.00 8,013
2024-05-31 Wilson Frank Anders Director A-Award A Restricted Stock Unit Award 8,013 0.00 8,013
2024-05-31 MCKEON BRIAN P Director A-Award A Restricted Stock Unit Award 8,013 0.00 8,013
2024-05-31 Lurker Nancy Director A-Award A Restricted Stock Unit Award 8,013 0.00 8,013
2024-05-31 LAURENCIN CATO T Director A-Award A Restricted Stock Unit Award 8,013 0.00 8,013
2024-05-31 GAYNOR RICHARD Director A-Award A Restricted Stock Unit Award 8,013 0.00 8,013
2024-05-31 Daglio David Angelo Jr. Director A-Award A Restricted Stock Unit Award 8,013 0.00 8,013
2024-05-31 Cooke Shane Director A-Award A Non Qualified Stock Option (Right to Buy) 17,492 23.40 409.3K 17,492
2024-05-31 Alva Emily Peterson Director A-Award A Restricted Stock Unit Award 8,013 0.00 8,013
2024-04-11 Lurker Nancy Director A-Award A Non Qualified Stock Option (Right to Buy) 22,103 24.99 552.4K 22,103
2024-03-18 Nichols Christian Todd Officer S-Sale D Ordinary Shares 10,417 28.10 292.7K 65,911
2024-03-05 Lurker Nancy Director 0 0.00 0
2024-02-27 Parisi Samuel Joseph Officer S-Sale D Ordinary Shares 2,559 29.65 75.9K 7,717
2024-02-26 Parisi Samuel Joseph Officer A-Award A Restricted Stock Unit Award 10,986 0.00 10,986
2024-02-26 POPS RICHARD F Director / Officer A-Award A Employee Stock Option (Right to Buy) 274,328 30.04 8.24M 274,328
2024-02-26 Nichols Christian Todd Officer A-Award A Employee Stock Option (Right to Buy) 87,602 30.04 2.63M 87,602
2024-02-26 Jackson Blair Curtis Officer A-Award A Restricted Stock Unit Award 33,289 0.00 33,289
2024-02-26 Hopkinson Craig C. Officer A-Award A Employee Stock Option (Right to Buy) 111,186 30.04 3.34M 111,186
2024-02-26 Gaffin David Joseph Officer A-Award A Employee Stock Option (Right to Buy) 111,186 30.04 3.34M 111,186
2024-02-26 Brown Iain Michael Officer A-Award A Employee Stock Option (Right to Buy) 90,971 30.04 2.73M 90,971
2024-02-23 Parisi Samuel Joseph Officer M-Exempt A Ordinary Shares 2,283 0.00 10,948
2024-02-23 Nichols Christian Todd Officer M-Exempt A Ordinary Shares 6,407 0.00 79,173
2024-02-23 LANDINE MICHAEL J Officer M-Exempt A Ordinary Shares 4,077 0.00 283,541
2024-02-23 Jackson Blair Curtis Officer M-Exempt D Restricted Stock Unit Award 8,737 0.00 26,214
2024-02-23 Hopkinson Craig C. Officer M-Exempt D Restricted Stock Unit Award 7,689 0.00 23,068
2024-02-23 Gaffin David Joseph Officer M-Exempt D Restricted Stock Unit Award 7,689 0.00 23,068
2024-02-23 Brown Iain Michael Officer M-Exempt A Ordinary Shares 5,825 0.00 118,931
2024-02-22 Parisi Samuel Joseph Officer M-Exempt A Ordinary Shares 3,114 0.00 9,573
2024-02-22 Nichols Christian Todd Officer M-Exempt A Ordinary Shares 7,108 0.00 75,922
2024-02-22 LANDINE MICHAEL J Officer F-InKind D Ordinary Shares 1,929 28.91 55.8K 279,464
2024-02-22 Jackson Blair Curtis Officer M-Exempt D Restricted Stock Unit Award 9,693 0.00 9,694
2024-02-22 Hopkinson Craig C. Officer M-Exempt D Restricted Stock Unit Award 12,278 0.00 12,279
2024-02-22 Gaffin David Joseph Officer M-Exempt D Restricted Stock Unit Award 7,431 0.00 7,432
2024-02-22 Brown Iain Michael Officer F-InKind D Ordinary Shares 3,156 28.91 91.2K 113,106
2024-02-20 Parisi Samuel Joseph Officer M-Exempt A Ordinary Shares 1,872 0.00 7,100
2024-02-20 Nichols Christian Todd Officer M-Exempt A Ordinary Shares 3,901 0.00 70,193
2024-02-20 LANDINE MICHAEL J Officer M-Exempt A Ordinary Shares 5,461 0.00 277,345
2024-02-20 Jackson Blair Curtis Officer M-Exempt A Ordinary Shares 4,680 0.00 149,634
2024-02-20 Hopkinson Craig C. Officer M-Exempt D Restricted Stock Unit Award 10,297 0.00 0
2024-02-20 Gaffin David Joseph Officer M-Exempt A Ordinary Shares 7,177 0.00 159,370
2024-02-20 Brown Iain Michael Officer M-Exempt D Restricted Stock Unit Award 4,680 0.00 0
2024-02-18 Parisi Samuel Joseph Officer M-Exempt A Ordinary Shares 2,034 0.00 5,934
2024-02-18 Nichols Christian Todd Officer F-InKind D Ordinary Shares 1,869 32.18 60.1K 66,292
2024-02-18 LANDINE MICHAEL J Officer F-InKind D Ordinary Shares 1,308 32.18 42.1K 271,884
2024-02-18 Jackson Blair Curtis Officer M-Exempt A Ordinary Shares 8,897 0.00 148,842
2024-02-18 Hopkinson Craig C. Officer M-Exempt D Restricted Stock Unit Award 8,897 0.00 17,793
2024-02-18 Gaffin David Joseph Officer M-Exempt A Ordinary Shares 6,355 0.00 154,062
2024-02-18 Brown Iain Michael Officer M-Exempt D Restricted Stock Unit Award 6,355 0.00 12,709
2024-02-15 LAURENCIN CATO T Director M-Exempt A Ordinary Shares 2,690 22.52 60.6K 17,859
2024-02-10 MCKEON BRIAN P Director M-Exempt A Ordinary Shares 4,533 0.00 24,229
2024-02-10 Daglio David Angelo Jr. Director M-Exempt D Restricted Stock Unit Award 4,533 0.00 0
2024-02-08 POPS RICHARD F Director / Officer A-Award A Ordinary Shares 218,551 0.00 1,271,432
2024-02-08 Nichols Christian Todd Officer A-Award A Ordinary Shares 27,012 0.00 69,941
2024-02-08 LANDINE MICHAEL J Officer A-Award A Ordinary Shares 21,485 0.00 271,927
2024-02-08 Jackson Blair Curtis Officer A-Award A Ordinary Shares 36,835 0.00 150,952
2024-02-08 Hopkinson Craig C. Officer A-Award A Ordinary Shares 46,658 0.00 103,217
2024-02-08 Gaffin David Joseph Officer A-Award A Ordinary Shares 28,240 0.00 156,190
2024-02-08 Brown Iain Michael Officer A-Award A Ordinary Shares 27,012 0.00 109,850
2024-02-01 Parisi Samuel Joseph Officer D Employee Stock Option (Right to Buy) 18,268 26.82 489.9K 0
2023-12-08 LAURENCIN CATO T Director M-Exempt A Ordinary Shares 4,163 0.00 16,169
2023-11-17 snyderman nancy lynn MD Director J-Other A Restricted Stock Unit Award 119 0.00 6,104
2023-11-17 Wright Christopher I Director J-Other A Non Qualified Stock Option (Right to Buy) 355 28.40 10.1K 18,128
2023-11-17 Wilson Frank Anders Director J-Other A Non Qualified Stock Option (Right to Buy) 254 30.72 7.8K 12,986
2023-11-17 POPS RICHARD F Director / Officer J-Other A Employee Stock Option (Right to Buy) 5,899 65.94 389.0K 300,899
2023-11-17 Nichols Christian Todd Officer J-Other A Employee Stock Option (Right to Buy) 885 20.03 17.7K 45,212
2023-11-17 MCKEON BRIAN P Director J-Other A Restricted Stock Unit Award 88 0.00 4,533
2023-11-17 LAURENCIN CATO T Director J-Other A Non Qualified Stock Option (Right to Buy) 254 30.72 7.8K 12,986
2023-11-17 LANDINE MICHAEL J Officer J-Other A Employee Stock Option (Right to Buy) 879 69.83 61.4K 44,879

Executive team

Top executives
EBIT / Employee
145.0K
Shares Outstanding
166.65M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Richard F. Pops Chief Executive Officer and Chairman 1.25M 5.02M 1.63M 17.5K 7.92M 63.43%
2 2025 Blair C. Jackson Executive Vice President, Chief Operating Officer; Former Interim Principal Financial Officer 736.5K 1.33M 1.32M 618.6K 17.5K 4.03M 65.95%
3 2025 Joshua Reed Senior Vice President, Chief Financial Officer 182.0K 1.16M 2.33M 118.3K 7.7K 3.80M 91.89%
4 2025 Craig C. Hopkinson, M.D. Executive Vice President, Research and Development and Chief Medical Officer 764.8K 1.10M 1.09M 642.5K 17.5K 3.62M 60.62%
5 2025 David J. Gaffin Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary 684.5K 1.10M 1.09M 575.0K 17.5K 3.47M 63.20%
6 2025 C. Todd Nichols Senior Vice President, Chief Commercial Officer 614.9K 866.7K 861.2K 430.4K 17.5K 2.79M 61.92%
7 2024 Richard F. Pops Chief Executive Officer and Chairman 1.21M 3.64M 4.04M 1.21M 17.3K 10.13M 75.86%
8 2024 Blair C. Jackson Executive Vice President, Chief Operating Officer; Former Interim Principal Financial Officer 715.0K 1.70M 1.99M 471.9K 17.3K 4.89M 75.38%
9 2024 Blair C. Jackson Executive Vice President, Chief Operating 715.0K 1.70M 1.99M 471.9K 17.3K 4.89M 75.38%
10 2024 Craig C. Hopkinson, M.D. Executive Vice President, Research and Development and Chief Medical Officer 742.6K 1.45M 1.64M 490.1K 17.3K 4.34M 71.23%
11 2024 David J. Gaffin Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary 664.6K 1.40M 1.64M 398.7K 17.3K 4.12M 73.74%
12 2024 C. Todd Nichols Senior Vice President, Chief Commercial Officer 597.0K 1.11M 1.29M 298.5K 17.3K 3.32M 72.50%
13 2024 Iain M. Brown Senior Vice President, Chief Financial Officer 256.7K 1.15M 1.34M 50.0K 17.3K 2.82M 88.51%
14 2023 Richard F. Pops Chief Executive Officer and Chairman 1.18M 2.90M 3.93M 1.41M 16.5K 9.44M 72.36%
15 2023 Richard F. Pops Chairman and Chief Executive Officer 1.18M 2.90M 3.93M 1.41M 16.5K 9.44M 72.36%
16 2023 Blair C. Jackson Executive Vice President, Chief Operating 650.0K 1.50M 1.89M 507.0K 16.5K 4.56M 74.28%
17 2023 Blair C. Jackson Executive Vice President, Chief Operating Officer; Former Interim Principal Financial Officer 650.0K 1.50M 1.89M 507.0K 16.5K 4.56M 74.28%
18 2023 Blair C. Jackson Executive Vice President, Chief Operating Officer and Chief Risk Officer 650.0K 1.50M 1.89M 507.0K 16.5K 4.56M 74.28%
19 2023 Craig C. Hopkinson, M.D. Executive Vice President, Research and Development and Chief Medical Officer 714.0K 1.32M 1.67M 514.1K 16.5K 4.23M 70.55%
20 2023 David J. Gaffin Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary 639.0K 1.32M 1.67M 498.4K 16.5K 4.14M 72.10%
21 2023 Iain M. Brown Senior Vice President, Chief Financial Officer 575.0K 997.1K 1.26M 359.4K 16.5K 3.21M 70.38%
22 2022 Richard F. Pops Chairman and Chief Executive Officer 1.14M 4.16M 3.85M 1.14M 15.3K 10.31M 77.66%
23 2022 Richard F. Pops Chief Executive Officer and Chairman 1.14M 4.16M 3.85M 1.14M 15.3K 10.31M 77.66%
24 2022 Craig C. Hopkinson, M.D. Executive Vice President, Research and Development and Chief Medical Officer 693.0K 1.63M 1.80M 415.8K 15.3K 4.55M 75.28%
25 2022 Blair C. Jackson Executive Vice President, Chief Operating Officer and Chief Risk Officer 600.0K 1.63M 1.80M 432.0K 15.3K 4.47M 76.57%
26 2022 Blair C. Jackson Executive Vice President, Chief Operating 600.0K 1.63M 1.80M 432.0K 15.3K 4.47M 76.57%
27 2022 David J. Gaffin Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary 614.2K 1.53M 1.68M 446.4K 15.3K 4.29M 74.93%
28 2022 Iain M. Brown Senior Vice President, Chief Financial Officer 550.0K 1.16M 1.28M 302.5K 15.3K 3.31M 73.81%
29 2021 Richard F. Pops Chairman and Chief Executive Officer 1.11M 3.10M 3.46M 1.16M 14.5K 8.85M 74.21%
30 2021 Craig C. Hopkinson, M.D. Executive Vice President, Research and Development and Chief Medical Officer 670.0K 1.61M 1.99M 442.2K 14.5K 4.73M 76.17%
31 2021 Blair C. Jackson Executive Vice President, Chief Operating Officer and Chief Risk Officer 540.0K 1.27M 1.57M 372.6K 14.5K 3.77M 75.41%
32 2021 David J. Gaffin Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary 586.3K 975.8K 1.20M 337.1K 14.5K 3.12M 69.91%
33 2021 Iain M. Brown Senior Vice President, Chief Financial Officer 500.0K 933.4K 1.15M 287.5K 14.5K 2.89M 72.22%
34 2020 Richard F. Pops Chairman and Chief Executive Officer 1.07M 2.55M 3.49M 912.7K 14.5K 8.04M 75.12%
35 2020 Craig C. Hopkinson, M.D. Executive Vice President, Research and Development and Chief Medical Officer 650.0K 1.30M 1.64M 351.0K 14.5K 3.96M 74.34%
36 2020 David J. Gaffin Senior Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary 569.3K 904.7K 1.15M 256.2K 14.5K 2.89M 70.94%
37 2020 James M. Frates Former Senior Vice President, Chief Financial Officer 575.5K 786.7K 996.1K 14.5K 2.37M 75.14%
38 2020 Michael J. Landine Senior Vice President, Corporate Development and Chief Risk Officer 516.5K 688.4K 871.6K 219.5K 14.5K 2.31M 67.52%
39 2019 Richard F. Pops Chairman and Chief Executive Officer 1.04M 4.22M 8.38M 980.0K 14.0K 14.64M 86.12%
40 2019 James A. Robinson Former President and Chief Operating Officer 269.0K 1.32M 2.56M 13.6K 4.16M 93.20%
41 2019 Craig C. Hopkinson, M.D. Executive Vice President, Research and Development and Chief Medical Officer 621.0K 895.7K 1.74M 388.1K 14.0K 3.66M 72.02%
42 2019 Craig C. Hopkinson Executive Vice President, Research and Development and Chief Medical Officer 621.0K 895.7K 1.74M 388.1K 14.0K 3.66M 72.02%
43 2019 David J. Gaffin Senior Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary 550.0K 895.7K 1.74M 343.8K 14.0K 3.54M 74.36%
44 2019 James M. Frates Former Senior Vice President, Chief Financial Officer 556.0K 758.9K 1.48M 278.0K 14.0K 3.08M 72.49%
45 2019 James M. Frates Senior Vice President, Chief Financial Officer 556.0K 758.9K 1.48M 278.0K 14.0K 3.08M 72.49%
46 2019 Michael J. Landine Senior Vice President, Corporate Development and Chief Risk Officer 499.0K 758.9K 1.48M 249.5K 14.0K 3.00M 74.56%
47 2018 Richard F. Pops Chairman and Chief Executive Officer 1.00M 4.88M 10.01M 1.15M 13.8K 17.06M 87.28%
48 2018 James A. Robinson Former President and Chief Operating Officer 545.2K 1.10M 3.16M 633.0K 1.29M 6.73M 63.37%
49 2018 James A. Robinson President and Chief Operating Officer 545.2K 1.10M 3.16M 633.0K 1.29M 6.73M 63.37%
50 2018 Mark P. Stejbach Former Senior Vice President and Chief Commercial Officer 445.2K 908.0K 1.85M 936.7K 4.14M 66.62%
51 2018 Kathryn L. Biberstein Former Executive Vice President, Chief Compliance Officer, Chief Administrative Officer and Chief Risk Officer 506.3K 1.18M 2.41M 22.9K 4.12M 87.14%
52 2018 Craig C. Hopkinson Executive Vice President, Research and Development and Chief Medical Officer 600.0K 908.0K 1.85M 420.0K 13.8K 3.79M 72.73%
53 2018 Craig C. Hopkinson Senior Vice President of Medicines Development and Medical Affairs, and Chief Medical Officer 600.0K 908.0K 1.85M 420.0K 13.8K 3.79M 72.73%
54 2018 Craig C. Hopkinson, M.D. Executive Vice President, Research and Development and Chief Medical Officer 600.0K 908.0K 1.85M 420.0K 13.8K 3.79M 72.73%
55 2018 James M. Frates Senior Vice President, Chief Financial Officer 536.7K 908.0K 1.85M 309.0K 13.8K 3.62M 76.24%
56 2018 James M. Frates Former Senior Vice President, Chief Financial Officer 536.7K 908.0K 1.85M 309.0K 13.8K 3.62M 76.24%
57 2018 David J. Gaffin Senior Vice President, Chief Legal Officer Chief Compliance Officer and Secretary 500.0K 908.0K 1.85M 325.0K 13.8K 3.60M 76.68%
58 2018 David J. Gaffin Senior Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary 500.0K 908.0K 1.85M 325.0K 13.8K 3.60M 76.68%
59 2017 Richard F. Pops Chairman and Chief Executive Officer 964.2K 1.91M 5.38M 1.11M 13.5K 9.38M 77.70%
60 2017 Shane M. Cooke President 605.1K 982.3K 2.29M 570.8K 27.1K 4.47M 73.09%
61 2017 Elliot W. Ehrich Executive Vice President, Research and Development 552.4K 818.6K 1.75M 414.0K 13.9K 3.55M 72.36%
62 2017 Kathryn L. Biberstein Executive Vice President, Chief Compliance Officer, Chief Administrative Officer and Chief Risk Officer 541.4K 818.6K 1.75M 405.7K 13.5K 3.53M 72.77%
63 2017 Kathryn L. Biberstein Former Executive Vice President, Chief Compliance Officer, Chief Administrative Officer and Chief Risk Officer 541.4K 818.6K 1.75M 405.7K 13.5K 3.53M 72.77%
64 2017 James M. Frates Senior Vice President, Chief Financial Officer and Treasurer 517.2K 654.8K 1.34M 298.2K 13.5K 2.83M 70.69%
65 2017 James M. Frates Senior Vice President, Chief Financial Officer 517.2K 654.8K 1.34M 298.2K 13.5K 2.83M 70.69%
66 2016 Richard F. Pops Chairman and Chief Executive Officer 911.2K 2.26M 4.82M 1.64M 13.3K 9.65M 73.37%
67 2016 Shane M. Cooke President 561.8K 903.6K 1.93M 725.0K 26.6K 4.14M 68.31%
68 2016 Elliot W. Ehrich Executive Vice President, Research and Development 533.7K 742.2K 1.61M 556.5K 13.3K 3.45M 68.04%
69 2016 Elliot W. Ehrich Executive Vice President, Research and Development and Chief Medical Officer 533.7K 742.2K 1.61M 556.5K 13.3K 3.45M 68.04%
70 2016 Kathryn L. Biberstein Executive Vice President, Chief Compliance Officer, Chief Administrative Officer, Chief Risk Officer and Secretary 523.1K 742.2K 1.61M 545.4K 13.3K 3.43M 68.47%
71 2016 Kathryn L. Biberstein Executive Vice President, Chief Compliance Officer, Chief Administrative Officer and Chief Risk Officer 523.1K 742.2K 1.61M 545.4K 13.3K 3.43M 68.47%
72 2016 Kathryn L. Biberstein Former Executive Vice President, Chief Compliance Officer, Chief Administrative Officer and Chief Risk Officer 523.1K 742.2K 1.61M 545.4K 13.3K 3.43M 68.47%
73 2016 James M. Frates Senior Vice President and Chief Financial Officer 499.7K 580.9K 1.22M 363.3K 13.3K 2.68M 67.28%
74 2016 James M. Frates Senior Vice President, Chief Financial Officer and Treasurer 499.7K 580.9K 1.22M 363.3K 13.3K 2.68M 67.28%
75 2016 James M. Frates Senior Vice President, Chief Financial Officer 499.7K 580.9K 1.22M 363.3K 13.3K 2.68M 67.28%
76 2015 Richard F. Pops 881.0K 2.85M 6.90M 1.77M 13.3K 12.41M 78.56%
77 2015 Richard F. Pops Chairman and Chief Executive Officer 881.0K 2.85M 6.90M 1.77M 13.3K 12.41M 78.56%
78 2015 Richard F. Pops Chairman and Chief Executive Officer James M. Frates Senior Vice President and Chief Financial Officer Rebecca J. Peterson 299.3K 3.24M 4.38M 663.2K 8.58M 88.79%
79 2015 Shane M. Cooke President 543.0K 1.26M 2.54M 735.3K 26.6K 5.10M 74.42%
80 2015 Communications Shane Cooke 543.0K 1.26M 2.54M 721.7K 26.6K 5.09M 74.62%
81 2015 Communications Shane Cooke President Elliot W. Ehrich 513.9K 1.07M 2.16M 604.9K 13.3K 4.36M 74.01%
82 2015 Elliot W. Ehrich Executive Vice President, Research and Development 513.9K 1.07M 2.16M 604.9K 13.3K 4.36M 74.01%
83 2015 Elliot W. Ehrich Executive Vice President, Research and Development and Chief Medical Officer 513.9K 1.07M 2.16M 604.9K 13.3K 4.36M 74.01%
84 2015 Kathryn L. Biberstein Executive Vice President, Chief Compliance Officer, Chief Administrative Officer and Chief Risk Officer 503.7K 1.07M 2.16M 592.8K 13.3K 4.33M 74.39%
85 2015 Kathryn L. Biberstein Executive Vice President, Chief Compliance Officer, Chief Administrative Officer, Chief Risk Officer and Secretary 503.7K 1.07M 2.16M 592.8K 13.3K 4.33M 74.39%
86 2015 James M. Frates Senior Vice President, Chief Financial Officer and Treasurer 483.2K 747.9K 1.52M 387.3K 13.3K 3.15M 71.94%
87 2015 James M. Frates Senior Vice President and Chief Financial Officer 483.2K 747.9K 1.52M 387.3K 13.3K 3.15M 71.94%
88 2015 Richard F. Pops Chairman and Chief Executive Officer James M. Frates 483.2K 747.9K 1.52M 387.3K 13.3K 3.15M 71.94%
89 2014 Richard F. Pops Chairman and Chief Executive Officer 854.7K 2.45M 5.41M 1.71M 13.0K 10.45M 75.29%
90 2014 Shane M. Cooke President 630.6K 990.4K 2.12M 721.2K 186.1K 4.65M 66.90%
91 2014 Communications Shane Cooke President 630.6K 990.4K 2.12M 721.2K 186.1K 4.65M 66.90%
92 2014 Elliot W. Ehrich Executive Vice President, Research and Development and Chief Medical Officer 468.1K 707.4K 1.53M 470.0K 13.1K 3.19M 70.17%
93 2014 Communications Shane Cooke President Elliot W. Ehrich Executive Vice President, Research and Development 468.1K 707.4K 1.53M 470.0K 13.1K 3.19M 70.17%
94 2014 Kathryn L. Biberstein Executive Vice President, Chief Compliance Officer, Chief Administrative Officer, Chief Risk Officer and Secretary 459.4K 660.2K 1.45M 460.6K 13.0K 3.04M 69.32%
95 2014 Richard F. Pops Chairman and Chief Executive Officer James M. Frates Senior Vice President and Chief Financial Officer Rebecca J. Peterson Former Senior Vice President, Corporate 332.1K 660.2K 1.45M 333.0K 13.1K 2.79M 75.66%
96 2014 Richard F. Pops Chairman and Chief Executive Officer James M. Frates Senior Vice President and Chief Financial Officer 468.7K 530.6K 1.18M 376.0K 13.1K 2.57M 66.56%
97 2014 James M. Frates Senior Vice President and Chief Financial Officer 468.7K 530.6K 1.18M 376.0K 13.1K 2.57M 66.56%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-06 DEFA14A
2026-04-06 DEF 14A
2026-03-27 PRE 14A
2025-05-12 DEFA14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-05 8-K
2026-05-05 10-Q
2026-05-04 4
2026-05-01 8-K/A
2026-05-01 4
2026-04-28 SC 13G
2026-04-28 SC 13G
2026-04-13 4
2026-04-06 DEFA14A
2026-04-06 DEF 14A

Executive team

NameTitleCompensationGender
Richard F. Pops Chairman & Chief Executive Officer 3M male
Craig C. Hopkinson Executive Vice President of Research & Development and Chief Medical Officer 1M
Blair C. Jackson Executive Vice President, Chief Risk Officer & Chief Operating Officer 1M male
David Joseph Gaffin Executive Vice President, Chief Legal Officer, Chief Compliance Officer & Secretary 1M male
Christian Todd Nichols Senior Vice President & Chief Commercial Officer 1M male
Joshua Reed Senior Vice President & Chief Financial Officer 744.0K male
Sandra Coombs Senior Vice President of Corporate Affairs & Investor Relations female
Stephen Schiavo Senior Vice President & Chief Human Resources Officer male
Thomas Harvey Chief Information Officer & Senior Vice President of IT male
Tom Skoff SVP & Chief Information Officer male
Declan O'Connor Senior Vice President of Operations and Environment, Health & Safety male
Samuel J. Parisi Interim Principal Accounting Officer & Vice President of Finance male
ESG Rating
B-
BIOTECHNOLOGY
2021
E (Environmental)
56.2 / 56.3
Company / Sector avg.
S (Social)
44.2 / 62.4
Company / Sector avg.
G (Governance)
54.3 / 60.9
Company / Sector avg.
ESG Total
51.6 / 59.9
Company / Sector avg.
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits